Does REMDESIVIR Cause Agranulocytosis? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Agranulocytosis have been filed in association with REMDESIVIR (Veklury). This represents 0.1% of all adverse event reports for REMDESIVIR.
6
Reports of Agranulocytosis with REMDESIVIR
0.1%
of all REMDESIVIR reports
0
Deaths
6
Hospitalizations
How Dangerous Is Agranulocytosis From REMDESIVIR?
Of the 6 reports, 6 (100.0%) required hospitalization, and 1 (16.7%) were considered life-threatening.
Is Agranulocytosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for REMDESIVIR. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does REMDESIVIR Cause?
Off label use (1,092)
Alanine aminotransferase increased (1,047)
Death (808)
Aspartate aminotransferase increased (713)
Bradycardia (652)
Acute kidney injury (605)
Covid-19 (570)
Drug ineffective (497)
Liver function test increased (447)
Respiratory failure (394)
What Other Drugs Cause Agranulocytosis?
CLOZAPINE (1,766)
CYCLOPHOSPHAMIDE (1,242)
RITUXIMAB (1,154)
SULFAMETHOXAZOLE\TRIMETHOPRIM (797)
PANTOPRAZOLE (599)
METHOTREXATE (550)
SODIUM (549)
EPIRUBICIN (491)
METAMIZOLE (438)
DOCETAXEL (436)
Which REMDESIVIR Alternatives Have Lower Agranulocytosis Risk?
REMDESIVIR vs REMERON
REMDESIVIR vs REMICADE
REMDESIVIR vs REMIFENTANIL
REMDESIVIR vs REMIMAZOLAM
REMDESIVIR vs REMODULIN